GLOBAL PARTNERS LP Overview
Industry: Oil & Gas Midstream
Sector: Energy
Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers in the New England states, Mid-Atlantic region, and New York. It is also involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. The company's Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, and residual oil, and propane to home heating oil retailers and wholesale distributors. This segment also aggregates crude oil through truck or pipeline in the mid-continent region of the United States and Canada, as well as transports it through rail and ships it through barge to refiners. Its Gasoline Distribution and Station Operations segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates gasoline stations and convenience stores; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. The company's Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector, as well as to commercial and industrial end-users; and sells custom blended fuels. The company serves as the general partner of the company. Global Partners LP was incorporated in 2005 and is based in Waltham, Massachusetts. Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers in the New England states, Mid- Read MoreMavefund brings filings, fundamentals, valuation, price history and news for GLOBAL PARTNERS LP into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $365.1M (reported). Operating income was $105.7M (+89% YoY). Net income was $70.1M (+275% YoY).
What changed
- Revenue reported to $365.1M.
- Operating income +89% YoY to $105.7M.
- Net income +275% YoY to $70.1M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Global Partners (GLP) Nears Earnings, Is It 6% Overvalued?
Headline from Yahoo Finance: Global Partners (GLP) Nears Earnings, Is It 6% Overvalued?
CVS Health CEO David Joyner warns private insurers won't cover GLP-1s for weight loss until drug prices drop
Headline from Yahoo Finance: CVS Health CEO David Joyner warns private insurers won't cover GLP-1s for weight loss until drug prices drop.
How Investors May Respond To CVS (CVS) Dividend Move And GLP‑1 Strategy Across Its Health Platform
Headline from Yahoo Finance: How Investors May Respond To CVS (CVS) Dividend Move And GLP‑1 Strategy Across Its Health Platform.
Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage
Headline from CNBC: Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage.
How Novo Nordisk’s GLP-1 Advertising Lawsuit Against Eli Lilly (LLY) Has Changed Its Investment Story
Headline from Yahoo Finance: How Novo Nordisk’s GLP-1 Advertising Lawsuit Against Eli Lilly (LLY) Has Changed Its Investment Story.
Hair loss with GLP-1 drugs is rare, but real, studies find
Headline from Reuters: Hair loss with GLP-1 drugs is rare, but real, studies find.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.